TYSABRI (natalizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** NATALIZUMAB

**Strength:** 300 mg/15mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Biogen Inc.

**Marketing category:** BLA (BLA125104)

**Pharmacologic class:** Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA]